This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, F.-M. C.
Right arrow Articles by Herrmann, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, F.-M. C.
Right arrow Articles by Herrmann, J. V.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2007, p. 3014-3016, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00459-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Cross-Resistance to Medical and Agricultural Azole Drugs in Yeasts from the Oropharynx of Human Immunodeficiency Virus Patients and from Environmental Bavarian Vine Grapes{triangledown}

Frank-Michael C. Müller,1,2* Andrea Staudigel,2 Stefanie Salvenmoser,1 Antje Tredup,1 Rudolf Miltenberger,3 and Josef V. Herrmann3

Pediatric Pulmonology and Infectious Diseases, Department of Pediatrics III, University Heidelberg, Heidelberg,1 Department of Pediatrics, University Würzburg, Würzburg,2 Bavarian State Institute for Viticulture and Horticulture, Veitshöchheim, Germany3

Received 3 April 2007/ Returned for modification 20 May 2007/ Accepted 25 May 2007

Cross-resistance among Candida albicans isolates from the oropharynges of human immunodeficiency virus-infected patients (n = 16) and environmental yeast strains of various species (n = 54) to medical and agricultural azole drugs was observed. Precautions against the unnecessary widespread use of azoles in the environment and human medicine are strongly recommended to prevent patients from acquiring azole-resistant yeasts.

* Corresponding author. Mailing address: Pediatric Pulmonology and Infectious Diseases, Dept. of Pediatrics III, University Heidelberg, Im Neuenheimer Feld 153, D-69120 Heidelberg, Germany. Phone: 49-6221-56-8356. Fax: 49-6221-56-33853. E-mail: Frank-Michael_Mueller{at}med.uni-heidelberg.de

{triangledown} Published ahead of print on 4 June 2007.

Antimicrobial Agents and Chemotherapy, August 2007, p. 3014-3016, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00459-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Serfling, A., Wohlrab, J., Deising, H. B. (2007). Treatment of a Clinically Relevant Plant-Pathogenic Fungus with an Agricultural Azole Causes Cross-Resistance to Medical Azoles and Potentiates Caspofungin Efficacy. Antimicrob. Agents Chemother. 51: 3672-3676 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»